---
title: "Kindly MD | 10-Q: FY2024 Q2 Revenue: USD 639.06 K"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/243066125.md"
datetime: "2025-06-04T09:07:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/243066125.md)
  - [en](https://longbridge.com/en/news/243066125.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/243066125.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/243066125.md) | [繁體中文](https://longbridge.com/zh-HK/news/243066125.md)


# Kindly MD | 10-Q: FY2024 Q2 Revenue: USD 639.06 K

Revenue: As of FY2024 Q2, the actual value is USD 639.06 K.

EPS: As of FY2024 Q2, the actual value is USD -0.26.

EBIT: As of FY2024 Q2, the actual value is USD -1.037 M.

### Segment Revenue

-   **Patient Care Services**: Revenue for the three months ended June 30, 2024, was $608,925, a decrease from $891,350 in the same period in 2023. For the six months ended June 30, 2024, revenue was $1,394,768, down from $1,959,305 in 2023.
-   **Product Retail Sales**: Revenue for the three months ended June 30, 2024, was $30,132, a decrease from $88,188 in the same period in 2023. For the six months ended June 30, 2024, revenue was $73,318, down from $180,578 in 2023.

### Operational Metrics

-   **Net Loss**: For the three months ended June 30, 2024, the net loss was - $1,319,653, compared to - $596,408 for the same period in 2023. For the six months ended June 30, 2024, the net loss was - $1,601,979, compared to - $777,387 in 2023.
-   **Operating Expenses**: Total operating expenses for the three months ended June 30, 2024, were $1,676,250, an increase from $1,580,827 in 2023. For the six months ended June 30, 2024, operating expenses were $2,742,406, a decrease from $2,946,377 in 2023.

### Cash Flow

-   **Operating Cash Flow**: Net cash used in operating activities for the six months ended June 30, 2024, was - $1,126,976, compared to - $274,964 in 2023.
-   **Free Cash Flow**: Not explicitly stated, but net cash provided by financing activities was $5,352,664 for the six months ended June 30, 2024, compared to $213,091 in 2023.

### Unique Metrics

-   **Insurance Reimbursements**: The company earned $91,553 in reimbursements from insurance payers during the three months ending June 30, 2024, a 163.7% increase over the $34,722 earned for the three months ending March 31, 2024.

### Future Outlook and Strategy

-   **Core Business Focus**: The company plans to continue shifting towards insurance billing with commercial and governmental payers, including Medicare and Medicaid, to optimize revenue and improve margins.
-   **Non-Core Business**: No specific plans related to divestitures or emerging segments were mentioned in the report.

### 相关股票

- [Nakamoto (NAKA.US)](https://longbridge.com/zh-CN/quote/NAKA.US.md)

## 相关资讯与研究

- [Gold Hunter shifts from quiet buildup to fully funded drilling push at Newfoundland gold district](https://longbridge.com/zh-CN/news/281261616.md)
- [Warren Buffett teams up with NBA superstar Stephen Curry for charity lunch, reviving iconic auction](https://longbridge.com/zh-CN/news/281182480.md)
- [How JPMorgan's plan to revive the American dream by going smaller would also help itself](https://longbridge.com/zh-CN/news/281225965.md)
- [04:00 ETM&A Source® Announces the 2026 Spring Conference & Deal Market](https://longbridge.com/zh-CN/news/281147895.md)
- [Oracle begins layoffs affecting thousands, CNBC reports](https://longbridge.com/zh-CN/news/281277680.md)